Results 81 to 90 of about 5,322 (214)

Delayed treatment with a tumor necrosis factor alpha blocker associated with worse outcomes in patients with spondyloarthritis: data from the Czech National Registry ATTRA

Therapeutic Advances in Musculoskeletal Disease, 2022
Introduction: The administration of biologic disease-modifying antirheumatic drugs, including tumor necrosis factor (TNF)-α inhibitors, is observed to interfere with the disease activity and progression.
Tomas Milota, Jana Hurnakova, Karel Pavelka, Zlatuse Kristkova, Lucie Nekvindova, Rudolf Horvath   +5 more
doaj   +1 more source

Ultrasonographic Evaluation of Nail Involvement in Patients With Axial Spondyloarthritis

Journal of Ultrasound in Medicine, Volume 43, Issue 5, Page 967-978, May 2024.
Objectives This study aimed to evaluate the nail units of patients with axial spondyloarthritis (ax‐SpA) using ultrasound and to identify any subclinical changes. We also aimed to examine the relationship between clinical enthesitis scores and nail involvement in patients with ax‐SpA. Methods The study included 40 patients with ax‐Spa, 40 patients with
Bilal Kulaksız, Deniz Palamar, Tugce Ozekli Misirlioglu, Kenan Akgun, Rana Terlemez   +4 more
wiley   +1 more source

Comparative Efficacy of Biologic Disease-Modifying Anti-Rheumatic Drugs for Non-Radiographic Axial Spondyloarthritis: A Systematic Literature Review and Bucher Indirect Comparisons

Rheumatology and Therapy, 2023
Introduction Biologic disease-modifying anti-rheumatic drugs (bDMARDs), including certolizumab pegol (CZP), are effective treatment options for the management of non-radiographic spondyloarthritis (nr-axSpA). In the absence of head-to-head comparisons in
Nurullah Akkoç, Carlos H. Arteaga, Simone E. Auteri, Marissa Betts, Kyle Fahrbach, Mindy Kim, Sandeep Kiri, Binod Neupane, Karl Gaffney, Philip J. Mease   +9 more
doaj   +1 more source

Patients’ Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients

Arthritis Care &Research, Volume 76, Issue 3, Page 350-358, March 2024.
Objective The objective of this study was to explore to what extent patients with axial spondyloarthritis (axSpA) link experienced pain in the neck, back, and hips to inflammation and/or structural damage. Methods Patients from the Groningen Leeuwarden Axial Spondyloarthritis (GLAS) cohort visiting the outpatient clinic between 2016 and 2019 filled out
Anne Kampman, Freke Wink, Davy Paap, Marlies Carbo, Mark Siderius, Stan Kieskamp, Fiona Maas, Anneke Spoorenberg, Suzanne Arends   +8 more
wiley   +1 more source

Microbiota and chronic inflammatory arthritis. an interwoven link [PDF]

, 2016
Background: Only recently, the scientific community gained insights on the importance of the intestinal resident flora for the host's health and disease.
D'Amelio, Raffaele, Laganà, Bruno, Manuela Rosado, M, Picchianti Diamanti, Andrea   +3 more
core   +2 more sources

Radiographic Progression in Sacroiliac Joints in Patients With Axial Spondyloarthritis: Results From a Five‐Year International Observational Study

ACR Open Rheumatology, Volume 6, Issue 2, Page 103-110, February 2024.
Objective To evaluate progression from nonradiographic (nr‐) to radiographic axial spondyloarthritis (r‐axSpA) over 5 years in patients with recently diagnosed (≤1 year) axSpA fulfilling the Assessment of SpondyloArthritis international Society (ASAS) classification criteria.
Denis Poddubnyy, Joachim Sieper, Servet Akar, Santiago Muñoz‐Fernández, Hildrun Haibel, Torsten Diekhoff, Mikhail Protopopov, Elisabeth Altmaier, Fabiana Ganz, Robert D. Inman   +9 more
wiley   +1 more source

Improved physical functioning, sleep, work productivity and overall health-related quality of life with bimekizumab in patients with axial spondyloarthritis: results from two phase 3 studies

RMD Open
Objective To assess the impact of bimekizumab on physical functioning, sleep, work productivity and overall health-related quality of life (HRQoL) in patients with non-radiographic (nr-) and radiographic (r-) axial spondyloarthritis (axSpA) in the phase ...
Annelies Boonen, Atul Deodhar, Martin Rudwaleit, Lianne S Gensler, Karl Gaffney, Maureen Dubreuil, Victoria Navarro-Compán, Vanessa Taieb, Carmen Fleurinck, Ute Massow, Thomas Vaux, Michael F Mørup, Christine de la Loge   +12 more
doaj   +1 more source

Predictive values of circulating miR‐146a and miR‐155 for disease activity and clinical response to TNF‐α blocking therapy in patients with ankylosing spondylitis

International Journal of Rheumatic Diseases, Volume 27, Issue 1, January 2024.
Abstract Objective Ankylosing spondylitis is an insidiously progressive and debilitating form of arthritis involving the axial skeleton. MicroRNAs have been reported to act as candidate biomarkers for ankylosing spondylitis diagnosis and progression. The study aimed to assess the roles of circulating miR‐146a and miR‐155 in ankylosing spondylitis and ...
Ling Liu, Xiaoyin Hu
wiley   +1 more source

Effects of Multidisciplinary Team-Based Nurse-led Transitional Care on Clinical Outcomes and Quality of Life in Patients With Ankylosing Spondylitis

Asian Nursing Research, 2019
Purpose: The purpose of this study is to investigate the impact of transitional care by a nurse-led multidisciplinary team (MDT) on clinical outcomes and quality of life of patients with ankylosing spondylitis.
Limin Liang, Yinghua Pan, Danchun Wu, Yongli Pang, Yuanyuan Xie, Hengying Fang   +5 more
doaj   +1 more source

Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data [PDF]

, 2022
Aileen Neilson, Gareth T. Jones, Gary J. Macfarlane, Ejaz Pathan, Paul McNamee   +4 more
openalex   +1 more source